1. Home
  2. CREX vs LITS Comparison

CREX vs LITS Comparison

Compare CREX & LITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Creative Realities Inc.

CREX

Creative Realities Inc.

HOLD

Current Price

$3.70

Market Cap

40.6M

Sector

Technology

ML Signal

HOLD

LITS

Lite Strategy Inc.

N/A

Current Price

$1.22

Market Cap

44.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CREX
LITS
Founded
N/A
2000
Country
United States
United States
Employees
N/A
4
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.6M
44.4M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
CREX
LITS
Price
$3.70
$1.22
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
33.7K
295.9K
Earning Date
04-14-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
2.86
N/A
EPS
N/A
N/A
Revenue
$18,437,000.00
N/A
Revenue This Year
$81.98
N/A
Revenue Next Year
$14.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.61
N/A
52 Week Low
$1.97
$0.95
52 Week High
$4.42
$3.03

Technical Indicators

Market Signals
Indicator
CREX
LITS
Relative Strength Index (RSI) 45.08 57.53
Support Level $3.52 $1.13
Resistance Level $3.77 $1.25
Average True Range (ATR) 0.17 0.05
MACD -0.03 0.01
Stochastic Oscillator 4.98 75.66

Price Performance

Historical Comparison
CREX
LITS

About CREX Creative Realities Inc.

Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to world-wide retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The Company operates in one reportable segment, marketing technology solutions. The company provides solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media.

About LITS Lite Strategy Inc.

Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.

Share on Social Networks: